Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL523499

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C=C1/C(=C\C=C2/CCC[C@]3(C)C(C4(CC#CC(C)(C)O)CC4)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O

Basic Information

ChEMBL ID CHEMBL523499
Phase Preclinical
Structure Type MOL
InChI Key RJSKEAKSUVWPIC-LMQQRSCXSA-N
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

422.6
MW (Da)
4.99
ALogP
3
HBA
3
HBD
60.7
PSA (Ų)
0.44
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C28H38O3
MW 422.61
Aromatic Rings 0
Heavy Atoms 31
NP-Likeness 2.11

Activity Summary

IC50 2 meas. best 10.47

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
PBMC
CHEMBL613107
IC50 10.47 10.47 0.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
PBMC IC50 = 0.034 nM 10.47 Inhibition of LPS-induced TNFalpha production in human PBMC after 24 hrs by ELIS... 19309155

Literature References

PubMed DOI Target Context # Activities
19309155 10.1021/jm801365a PBMC 2

Data from ChEMBL 36 via Core Engine